Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

OncoArendi Therapeutics Announces Selection of Its Second Clinical Development Candidate: OATD-02 Fo

b3cnewswireJune 27, 2017

Tag: OncoArendi Therapeutics

PharmaSources Customer Service